Literature DB >> 9150265

Impaired lysogenisation of the Escherichia coli rpoA341 mutant by bacteriophage lambda is due to the inability of CII to act as a transcriptional activator.

M Obuchowski1, H Giladi, S Koby, A Szalewska-Pałasz, A Wegrzyn, A B Oppenheim, M S Thomas, G Wegrzyn.   

Abstract

The C-terminus of the alpha subunit of Escherichia coli RNA polymerase is known to function in transcriptional activation at certain promoters. This region was previously shown to be necessary for full activation of the pE promoter by the phage lambda CII protein in vitro. In this work we investigated the inability of phage lambda to follow the lysogenic pathway in cells carrying the point mutation rpoA341 (a change of lysine 271 to glutamic acid). We found that neither overexpression of the cII gene nor stabilisation of the CII protein by the can1 mutation or by cIII gene overexpression was able to suppress the block in lysogenisation. In contrast, the lambda cin1 phage, which carries a CII-independent promoter for the expression of the cI gene, was able to efficiently lysogenise the rpoA341 mutant strain. Furthermore, the rpoA341 mutation prevented the activation of pE-lacZ and pI-lacZ transcriptional fusions by CII. Therefore we conclude that transcriptional activation by the cII gene product is abolished by the rpoA341 mutation, most probably due to impaired interaction between the CII activator and mutant RNA polymerase. The inability of RNA polymerase to respond to CII results in the impairment of lysogenisation of the rpoA341 mutant by phage lambda.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150265     DOI: 10.1007/s004380050420

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  10 in total

1.  Interactions among CII protein, RNA polymerase and the lambda PRE promoter: contacts between RNA polymerase and the -35 region of PRE are identical in the presence and absence of CII protein.

Authors:  Michael T Marr; Jeffrey W Roberts; Susan E Brown; Matthew Klee; Gary N Gussin
Journal:  Nucleic Acids Res       Date:  2004-02-10       Impact factor: 16.971

2.  Stability of CII is a key element in the cold stress response of bacteriophage lambda infection.

Authors:  M Obuchowski; Y Shotland; S Koby; H Giladi; M Gabig; G Wegrzyn; A B Oppenheim
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

3.  Bacteriophage lambda cIII gene product has an additional function apart from inhibition of cII degradation.

Authors:  B Latała; M Obuchowski; G W grzyn
Journal:  Virus Genes       Date:  2001-03       Impact factor: 2.332

4.  Role of the bacteriophage lambda exo-xis region in the virus development.

Authors:  J M Łoś; M Łoś; A Wegrzyn; G Wegrzyn
Journal:  Folia Microbiol (Praha)       Date:  2008-12-16       Impact factor: 2.099

5.  Structure of lambda CII: implications for recognition of direct-repeat DNA by an unusual tetrameric organization.

Authors:  Ajit B Datta; Santosh Panjikar; Manfred S Weiss; Pinak Chakrabarti; Pradeep Parrack
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

6.  Role of the RNA polymerase alpha subunits in CII-dependent activation of the bacteriophage lambda pE promoter: identification of important residues and positioning of the alpha C-terminal domains.

Authors:  Barbara Kedzierska; David J Lee; Grzegorz Wegrzyn; Stephen J W Busby; Mark S Thomas
Journal:  Nucleic Acids Res       Date:  2004-02-03       Impact factor: 16.971

7.  The Escherichia coli cmlA gene encodes the multidrug efflux pump Cmr/MdfA and is responsible for isopropyl-beta-D-thiogalactopyranoside exclusion and spectinomycin sensitivity.

Authors:  C Bohn; P Bouloc
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

8.  The Bacteriophage Lambda CII Phenotypes for Complementation, Cellular Toxicity and Replication Inhibition Are Suppressed in cII-oop Constructs Expressing the Small RNA OOP.

Authors:  Karthic Rajamanickam; Sidney Hayes
Journal:  Viruses       Date:  2018-03-07       Impact factor: 5.048

9.  RNA polymerase mutations cause cephalosporin resistance in clinical Neisseria gonorrhoeae isolates.

Authors:  Samantha G Palace; Yi Wang; Daniel Hf Rubin; Michael A Welsh; Tatum D Mortimer; Kevin Cole; David W Eyre; Suzanne Walker; Yonatan H Grad
Journal:  Elife       Date:  2020-02-03       Impact factor: 8.140

10.  Phage lambda CIII: a protease inhibitor regulating the lysis-lysogeny decision.

Authors:  Oren Kobiler; Assaf Rokney; Amos B Oppenheim
Journal:  PLoS One       Date:  2007-04-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.